Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Graft vs Host Disease”

567 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 567 results

Not applicableLooking for participantsNCT04745221
What this trial is testing

Efficacy and Safety of Auto-FMT in Preventing aGVHD

Who this might be right for
Graft Versus Host Disease, Acute
The First Affiliated Hospital of Soochow University 100
Testing effectiveness (Phase 2)Ended earlyNCT03263767
What this trial is testing

Post Transplant Cyclophosphamide (PTCY) as Sole Graft Versus Host Disease (GVHD) Prophylaxis for Matched Allotransplant: CYRIC

Who this might be right for
Graft Versus Host Disease
Nantes University Hospital 47
Not applicableEnded earlyNCT00255684
What this trial is testing

Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
University of Rochester 16
Testing effectiveness (Phase 2)Ended earlyNCT00555048
What this trial is testing

Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 1
Not applicableStudy completedNCT06247891
What this trial is testing

Endocytoscopy of Upper Gastrointestinal Tract in Acute Graft-versus-host Disease: a Pilot Study

Who this might be right for
Endocytoscopy
Ruijin Hospital 14
Large-scale testing (Phase 3)Looking for participantsNCT06294691
What this trial is testing

Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases

Who this might be right for
Acute Graft-versus-host Disease
Anhui Provincial Hospital 198
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100
Testing effectiveness (Phase 2)Ended earlyNCT01757197
What this trial is testing

Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)

Who this might be right for
Glucocorticosteroid Refractory Acute GVHD
Weill Medical College of Cornell University 2
Not applicableAvailableNCT05047328
What this trial is testing

Early Access Program With Inolimomab in Steroid-refractory Acute Graft Versus Host Disease

Who this might be right for
Steroid Resistant Acute Graft Versus Host Disease
ElsaLys Biotech
Very early researchUnknownNCT04285424
What this trial is testing

FMT for Steroid Resistant Gut Acute GVHD

Who this might be right for
Stem Cell Transplant ComplicationsAcute Graft-Versus-Host DiseaseFecal Microbiota Transplantation
Affiliated Hospital to Academy of Military Medical Sciences 30
Not applicableStudy completedNCT00619879
What this trial is testing

Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies

Who this might be right for
Leukemia, Myelogenous, ChronicLeukemia, Lymphoblastic, AcuteLeukemia, Myelogenous, Acute+2 more
Ann & Robert H Lurie Children's Hospital of Chicago 81
Post-approval studies (Phase 4)Looking for participantsNCT06462469
What this trial is testing

Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease

Who this might be right for
Steroid-refractory Acute Graft Versus Host Disease
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT00186628
What this trial is testing

Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

Who this might be right for
Leukemia, Mast-CellMantle-cell Lymphoma
Stanford University 36
Testing effectiveness (Phase 2)WithdrawnNCT01882387
What this trial is testing

Efficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
Tarix Pharmaceuticals
Testing effectiveness (Phase 2)UnknownNCT04688021
What this trial is testing

A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.

Who this might be right for
LeukemiaGraft-versus-host-disease
Yi Luo 46
Not applicableStudy completedNCT03042676
What this trial is testing

Electronic Database for the Follow up of the ATG_FamilyStudy

Who this might be right for
GVHD, ChronicAcute LeukemiaStem Cell Transplant Complications
IRCCS Azienda Ospedaliero-Universitaria di Bologna 104
Testing effectiveness (Phase 2)UnknownNCT00377468
What this trial is testing

Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study)

Who this might be right for
Complex Regional Pain SyndromesCRPS
Ludwig-Maximilians - University of Munich 100
Testing effectiveness (Phase 2)Study completedNCT03847844
What this trial is testing

UCMSCs as Front-line Approach of Treatment for Patients With aGVHD

Who this might be right for
Acute-graft-versus-host Disease
Cytopeutics Sdn. Bhd. 26
Testing effectiveness (Phase 2)UnknownNCT03357159
What this trial is testing

Anti T-lymphocyte Immunoglobulin With Post Transplant Cyclophosphamide to Prevent GVHD Post Allogeneic Transplantation

Who this might be right for
Graft Versus Host Disease
Sheba Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00014469
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Memorial Sloan Kettering Cancer Center
Load More Results